M
Mathijs P. Hendriks
Researcher at University of Twente
Publications - 67
Citations - 1336
Mathijs P. Hendriks is an academic researcher from University of Twente. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 46 publications receiving 471 citations. Previous affiliations of Mathijs P. Hendriks include Radboud University Nijmegen Medical Centre & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Renu R. Bahadoer,Esmée A Dijkstra,Boudewijn van Etten,Corrie A.M. Marijnen,Corrie A.M. Marijnen,Hein Putter,Elma Meershoek-Klein Kranenbarg,Annet G H Roodvoets,Iris D. Nagtegaal,Regina G. H. Beets-Tan,Lennart Blomqvist,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemovic,Andrés Cervantes,Per Nilsson,Bengt Glimelius,Cornelis J.H. van de Velde,Geke A. P. Hospers,L. Østergaard,F. Svendsen Jensen,P. Pfeiffer,K.E.J. Jensen,M.P. Hendriks,W.H. Schreurs,H.P. Knol,J.J. van der Vliet,J.B. Tuynman,A.M.E. Bruynzeel,E.D. Kerver,S. Festen,M E van Leerdam,G.L. Beets,L.G.H. Dewit,C.J.A. Punt,Pieter J. Tanis,E.D. Geijsen,P. Nieboer,W.A. Bleeker,A.J. Ten Tije,R.M.P.H. Crolla,A.C.M. van de Luijtgaarden,J.W.T. Dekker,J.M. Immink,F.J.F. Jeurissen,A.W.K.S. Marinelli,H.M. Ceha,T.C. Stam,P. Quarles an Ufford,W.H. Steup,A.L.T. Imholz,R.J.I. Bosker,J.H.M. Bekker,G.J. Creemers,G.A.P. Nieuwenhuijzen,H. van den Berg,W.M. van der Deure,R.F. Schmitz,J.M. van Rooijen,A.F.T. Olieman,A.C.M. van den Bergh,Derk Jan A. de Groot,Klaas Havenga,Jannet C. Beukema,J. de Boer,P.H.J.M. Veldman,E.J.M. Siemerink,J.W.P. Vanstiphout,B. de Valk,Q.A.J. Eijsbouts,M.B. Polée,C. Hoff,A. Slot,H.W. Kapiteijn,K.C.M.J. Peeters,F.P. Peters,P.A. Nijenhuis,S.A. Radema,H. de Wilt,P. Braam,G.J. Veldhuis,D. Hess,T. Rozema,O. Reerink,D. Ten Bokkel Huinink,A. Pronk,Janet R. Vos,M. Tascilar,G.A. Patijn,C. Kersten,O. Mjåland,M. Grønlie Guren,A.N. Nesbakken,J. Benedik,I. Edhemovic,V. Velenik,J. Capdevila,E. Espin,R. Salazar,S. Biondo,V. Pachón,J. die Trill,J. Aparicio,E. Garcia Granero,M.J. Safont,J.C. Bernal,A. Cervantes,A. Espí Macías,L. Malmberg,G. Svaninger,H. Hörberg,G. Dafnis,A. Berglund,L. Österlund,K. Kovacs,J. Hol,S. Ottosson,G. Carlsson,C. Bratthäll,J. Assarsson,B.L. Lödén,P. Hede,I. Verbiené,O. Hallböök,A. Johnsson,M.L. Lydrup,K. Villmann,P. Matthiessen,J.H. Svensson,J. Haux,S. Skullman,T. Fokstuen,Torbjörn Holm,P. Flygare,M. Walldén,B. Lindh,O. Lundberg,C. Radu,L. Påhlman,A. Piwowar,K. Smedh,U. Palenius,S. Jangmalm,P. Parinkh,H. Kim,M.L. Silviera +147 more
TL;DR: The Rectal cancer And Preoperative Induction therapy followed by Dedicated Operation (RAPIDO) trial aimed to reduce distant metastases without compromising locoregional control.
Journal ArticleDOI
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
Maxime J M van der Valk,Corrie A.M. Marijnen,Corrie A.M. Marijnen,Boudewijn van Etten,Esmée A Dijkstra,Denise E. Hilling,Elma Meershoek-Klein Kranenbarg,Hein Putter,Annet G H Roodvoets,Renu R. Bahadoer,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemovic,Andrés Cervantes,Derk Jan A. de Groot,Per Nilsson,Bengt Glimelius,Cornelis J.H. van de Velde,Geke A. P. Hospers +20 more
TL;DR: Although considerable toxicity was observed during preoperative therapy, this did not lead to differences in surgical procedures or postoperative complications, and high compliance of preoperative systemic treatment could be achieved with the experimental approach.
Journal ArticleDOI
Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival.
Arturo Moncada-Torres,Marissa C. van Maaren,Mathijs P. Hendriks,Sabine Siesling,Gijs Geleijnse +4 more
TL;DR: It is shown that explainable ML can generate explicit knowledge of how models make their predictions, which is crucial in increasing the trust and adoption of innovative ML techniques in oncology and healthcare overall.
Journal ArticleDOI
Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.
Geke A. P. Hospers,Renu R. Bahadoer,Esmée A Dijkstra,Boudewijn van Etten,Corrie A.M. Marijnen,Hein Putter,Elma Meershoek – Klein Kranenbarg,Annet G H Roodvoets,Iris D. Nagtegaal,Regina G. H. Beets-Tan,Lennart Blomqvist,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemovic,Andrés Cervantes,Per Nilsson,Bengt Glimelius,Cornelis J.H. van de Velde +19 more
TL;DR: Local control in locally advanced rectal cancer (LARC) has improved, however, systemic relapses remain high even with postoperative chemotherapy, possibly due to low compliance.
Journal ArticleDOI
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.
Johannes J.M. Kwakman,Lieke H.J. Simkens,J. M. van Rooijen,A.J. van de Wouw,A.J. ten Tije,G.J.M. Creemers,Mathijs P. Hendriks,M. Los,R.J. van Alphen,Marco B. Polee,Erik W. Muller,A.M.T. van der Velden,T. Van Voorthuizen,Miriam Koopman,Linda Mol,E. van Werkhoven,C.J.A. Punt +16 more
TL;DR: Treatment with S-1 in Western mCRC patients is associated with a significantly lower incidence of HFS compared with capecitabine, with comparable efficacy.